why choose us

First received: July 28, 2022

Clinical Trial: Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort

Study Status: Completed

Recruit Status: RECRUITING

Condition: Long Haul COVID

Study Type: INTERVENTIONAL


Official Title: Comparative Cohort Study of Post-acute COVID-19 Infection With a Nested, Randomized Controlled Trial of Ivabradine for Those With Postural Orthostatic Tachycardia Syndrome.

Brief Summary: The purpose of the study is three-fold.The primary aim is to identify the proportion of Long-Haul COVID (LHC) and non-LHC volunteers with relevant symptoms actually have postural orthostatic tachycardia syndrome (POTS).The second is to determine benefit of ivabradine treatment.Ivabradine is a drug approved to treat tachycardia in persons with heart failure.The third is to characterize risk factors and outcomes among volunteers with and without LHC.This will include comparison with COVID-19-positive individuals who…

Read more